Company / Share Buybacks
Ligand Pharmaceuticals, Inc. Share Buybacks History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$15.0M
FY2025
5-year range
$0 / $15.0M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#34 of 48
Health Care
What the data says
At $15M, Ligand Pharmaceuticals, Inc.'s share buybacks ranks #34 of 48 in the Health Care sector. Improved from $0 to $15M over the past 2 years.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of -28.1%.
Improved from $0 to $15M over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -28.1%
- 10-Year CAGR
- -
Sector benchmark
#34 of 48 in Health CareTop 71% of 48This company $15.0M Sector average $611.9M
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -28.1%, indicating a declining trend.
- Ranks #34 out of 48 companies in the Health Care sector.
- Peak share buybacks was recorded in FY2019.
- Lowest share buybacks in the period was in FY2024.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.0M | - |
| FY2024 | $0 | - |
| FY2023 | $0 | - |
| FY2022 | $0 | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $78.0M | -82.8% |
| FY2019 | $453.0M | +268.7% |
| FY2018 | $122.9M | +6149.6% |
| FY2017 | $2.0M | -49.6% |
| FY2016 | $3.9M | +697.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026